TABLE 2.
Sources of MNV isolates
| Virus | GenBank accession no. | Date of isolation | Location of research colony | Country of origin | Mouse strain | Genetic deficiency(ies) or descriptiond | Symptom |
|---|---|---|---|---|---|---|---|
| MNV1 | AY228235 | 2002 | Washington University | U.S. | 129Pas | IFN-αβR−/− IFN-γR−/− | Sporadic lethality (39) |
| WU11 | EU004663 | March 2005 | Washington University | U.S. | C57BL/6 | OTI/Rag1−/− IFN-γR−/− | Diarrhea |
| WU12 | EU004664 | April 2005 | Washington University | U.S. | BALB/c | β2M−/− | Diarrhea |
| WU20a | EU004665 | July 2005 | Washington University | U.S. | C57BL/6 | Rag1−/− IFN-γR−/− | None |
| WU21a | EU004666 | July 2005 | Washington University | U.S. | C57BL/6 | Rag1−/− IFN-γR−/− | None |
| WU22a | EU004667 | July 2005 | Washington University | U.S. | C57BL/6 | Rag1−/− IFN-γR−/− | None |
| WU23b | EU004668 | July 2005 | Washington University | U.S. | C57BL/6 | OTI/Rag1−/− IFN-γR−/− | Diarrhea |
| WU24b | EU004669 | July 2005 | Washington University | U.S. | C57BL/6 | OTI/Rag1−/− IFN-γR−/− | None |
| WU25 | EU004670 | July 2005 | Washington University | U.S. | C57BL/6 | OTII/Rag1−/− IFN-γR−/− | Diarrhea |
| WU26 | EU004671 | August 2005 | Washington University | U.S. | BALB/c | β2M−/− | None |
| CR1 | EU004672 | October 2005 | Charles River Laboratories | U.S. | CD-1 | None | |
| CR3 | EU004673 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR4 | EU004674 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR5 | EU004675 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR6 | EU004676 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR7 | EU004677 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR10 | EU004678 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR11 | EU004679 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR13 | EU004680 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR15 | EU004681 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR17 | EU004682 | October 2005 | Charles River Laboratories | U.S. | C57BL/6 | GM | None |
| CR18 | EU004683 | October 2005 | Charles River Laboratories | Germany | DBA/1 | None | |
| UM2 | DQ223041 | 2005 | NRc | U.S. | Samples pooled from WT and GM mice (31) | NR | |
| UM3 | DQ223042 | 2005 | NR | U.S. | Samples pooled from WT and GM mice (31) | NR | |
| UM4 | DQ223043 | 2005 | NR | U.S. | Samples pooled from WT and GM mice (31) | NR | |
| Berlin | DQ911368 | April 2006 | Robert Koch Institute | Germany | NR | IFN-γR−/− | NR |
WU20, WU21, and WU22 were isolated from littermates.
WU23 and WU24 were isolated from littermates.
NR, not reported.
IFN-αβR, alpha/beta interferon receptor; IFN-γR, gamma interferon receptor; OTI and OTII, ovalbumin-specific T-cell receptor transgenic; Rag1, recombination activation gene; β2M, β2-microglobulin; GM, genetically modified; WT, wild-type.